Literature DB >> 6250094

Further ultrastructural observations of virus morphogenesis and myelin pathology in JHM virus encephalomyelitis.

H J Fleury, R D Sheppard, M B Bornstein, C S Raine.   

Abstract

Groups of 3, 17, and 28-day-old Swiss mice were inoculated intracerebrally with JHM virus, the neurotropic strain of mouse hepatitis virus (MHV), and studied serially by virologic and morphologic techniques. Beginning 2--5 days post-inoculation, all groups of infected mice developed CNS lesions which were destructive in the 3-day-old group and demyelinative in the 17 and 28-day-old animals. Infectious virus could be isolated from the brain, spinal cord, and liver. Electron microscopy demonstrated the virus to be pantropic in the CNS with virions occurring within ependymal cells, astrocytes, neurons, oligodendrocytes, endothelial cells, and cell of haematogenous origin. Giant cell formation was a constant feature. In regions of demyelination, oligodendrocytes exhibited a propensity to proliferative aberrant membrane. Myelin degradation was accompanied by membrane vesiculation and by the stripping action of macrophages. The lesions were not due to CNS elements in the inoculum since in animals inoculated with normal CNS suspensions from appropriate age groups failed to show lesions. The morphogenesis of JHM virions was followed ultrastructurally as was the formation of syncytia in the different cell types. In addition to delineating virus morphogenesis and myelin pathology, the results underscore the pantropic nature of JHM virus in the CNS, the synstemic nature of the infection, and that oligodendrocytes were the principal targets.

Entities:  

Mesh:

Year:  1980        PMID: 6250094     DOI: 10.1111/j.1365-2990.1980.tb00288.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  22 in total

1.  Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis.

Authors:  M T Lin; S A Stohlman; D R Hinton
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 2.  The pathogenesis of murine coronavirus infection of the central nervous system.

Authors:  Thomas E Lane; Martin P Hosking
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

3.  Persistent coronavirus infection of progenitor oligodendrocytes.

Authors:  Yin Liu; Xuming Zhang
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

4.  Mouse hepatitis virus strain JHM infects a human hepatocellular carcinoma cell line.

Authors:  P J Koetters; L Hassanieh; S A Stohlman; T Gallagher; M M Lai
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

5.  Coronavirus JHM-induced demyelinating encephalomyelitis in rats: influence of immunity on the course of disease.

Authors:  H Wege; R Watanabe; M Koga; V Ter Meulen
Journal:  Prog Brain Res       Date:  1983       Impact factor: 2.453

6.  Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization.

Authors:  E Lavi; D H Gilden; M K Highkin; S R Weiss
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

7.  The Biology of Persistent Infection: Inflammation and Demyelination following Murine Coronavirus Infection of the Central Nervous System.

Authors:  Martin P Hosking; Thomas E Lane
Journal:  Curr Immunol Rev       Date:  2009-05-04

8.  NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis.

Authors:  Kevin B Walsh; Lewis L Lanier; Thomas E Lane
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

9.  In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases.

Authors:  O Sorensen; M B Coulter-Mackie; S Puchalski; S Dales
Journal:  Virology       Date:  1984-09       Impact factor: 3.616

Review 10.  Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.

Authors:  Brett S Marro; Caroline A Blanc; Jeanne F Loring; Michael D Cahalan; Thomas E Lane
Journal:  Expert Rev Neurother       Date:  2014-10       Impact factor: 4.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.